| Multicentre trial of naproxen and phenylbutazone in acute gout. | |
| | |
MedLine Citation:
|
PMID: 843115 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Naproxen 750 mg as a single dose followed by 250 mg three times daily has been compared with phenylbutazone 200 mg four times daily for 48 hours followed by 200 mg three times daily for treatment of acute gout in an open study on 41 patients. The drugs were equally effective with few and relatively mild side effects. Naproxen is a useful alternative agent for the treatment of acute gout. |
| | |
Authors:
|
R A Sturge; J T Scott; E B Hamilton; S P Liyanage; A S Dixon; J Davies; C Engler |
Related Documents
:
|
6406435 - Evaluation of the safety and efficacy of bupropion in depression. 2529295 - Response of panic disorder to fixed doses of alprazolam or imipramine. 12815555 - Oxymetholone for the treatment of hiv-wasting: a double-blind, randomized, placebo-cont... 3310585 - Efficacy and tolerance of ethmozine (moricizine hcl) in placebo-controlled trials. 9239805 - Effect of activated charcoal on rifampicin absorption in man. 1310965 - Potential improvement of three dimension treatment planning and proton therapy in the o... |
Publication Detail:
|
Type: Comparative Study; Journal Article |
Journal Detail:
|
Title: Annals of the rheumatic diseases Volume: 36 ISSN: 0003-4967 ISO Abbreviation: Ann. Rheum. Dis. Publication Date: 1977 Feb |
Date Detail:
|
Created Date: 1977-04-15 Completed Date: 1977-04-15 Revised Date: 2009-11-18 |
Medline Journal Info:
|
Nlm Unique ID: 0372355 Medline TA: Ann Rheum Dis Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 80-2 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acute Disease Adult Aged Female Gout / drug therapy* Humans Male Middle Aged Naphthaleneacetic Acids / therapeutic use* Naproxen / therapeutic use* Phenylbutazone / therapeutic use* |
| Chemical | |
Reg. No./Substance:
|
0/Naphthaleneacetic Acids; 22204-53-1/Naproxen; 50-33-9/Phenylbutazone |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Radiographic changes in early rheumatoid disease.
Next Document: HLA antigens in systemic lupus erythematosus.